The latest news for pharma industry insiders.
A Fun and Insightful Exploration of Behavioral Science
Sharing an entertaining dive into the origins, milestones, and future of behavioral economics—where lessons can be applied to clinical practice.
A Conversation Veteran Healthcare Lobbyist Paul Kelly | DC Roundtable
A limited pharmacy benefit manager (PBM) reform bill may be used as a "pay for" to offset the costs of extending Medicare telehealth flexibilities, shares Kelly, of Capitol Advocacy & Government Affairs.
Big Tech Moves More AI Spending Abroad
So far this year, Microsoft and Amazon have earmarked more than $40 billion combined for investments in AI-related and data center projects worldwide.
The "Insulin Delivery Systems - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Insulin Delivery Systems estimated at US$13.4 Billion in the year 2023, is projected to reach a revised size of US$16.8 Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2023-2030.
Stephanie Ramos (she/her) on LinkedIn:
#RFID supports a more efficient and accurate medication-use process that can enhance #patientsafety, help prevent drug diversion, and give clinicians more time for patient care.https://ow.ly/Q5sY50RAizt Pharmaceutical Commerce Magazine Fresenius Kabi #GS1Standards
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.